Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.62 |
| ▸ | MAPT | P10636 | 6/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 6/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 4/20 | 0.58 |
| ▸ | TCF4 | P15884 | 1/20 | 0.57 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL645648 | 0.80 | POLB (0.68) | KMT2AALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL21225209 | 0.78 | ALDH1A1 (0.55) | KMT2AALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL16218479 | 0.77 | KMT2A (0.60) | KMT2AALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL14315202 | 0.77 | ALDH1A1 (1.00) | KMT2AALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL12222500 | 0.76 | POLB (0.67) | KMT2AALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL16218484 | 0.75 | KMT2A (0.61) | KMT2AALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL14325640 | 0.75 | RAB9A (0.68) | KMT2AALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL16221729 | 0.75 | ALDH1A1 (1.00) | KMT2AALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL28802526 | 0.75 | ALOX12 (0.43) | KMT2AALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL29728425 | 0.75 | ALOX12 (0.43) | KMT2AALDH1A1MAPTKDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114878727-A | Method for determining hymexazol residues in tobacco | 合肥高尔生命健康科学研究院有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-114878727-B | Method for determining hymexazol residues in tobacco | 合肥高尔生命健康科学研究院有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-114878727-A | Method for determining hymexazol residues in tobacco | 合肥高尔生命健康科学研究院有限公司 | 2022-08-09 | — | — | CN | disclosed |
| WO-2019152731-A1 | ANDROGEN RECEPTOR ANTAGONISTS | ALPINE ANDROSCIENCES, INC. (US) | 2019-08-08 | — | — | WO | disclosed |
| US-20080281105-A1 | Novel Quinolinium Salts and Derivatives | IMMUSOL INCORPORATED (US) | 2008-11-13 | — | — | US | disclosed |
| CN-101106992-A | Novel quinolinium salts and derivatives | IMMUSOL INC (US) | 2008-01-16 | — | — | CN | disclosed |
| EP-1841428-A1 | NOVEL QUINOLINIUM SALTS AND DERIVATIVES | Immusol Incorporated (US) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006078754-A1 | NOVEL QUINOLINIUM SALTS AND DERIVATIVES | IMMUSOL INCORPORATED (US) | 2006-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080281105-A1 | Novel Quinolinium Salts and Derivatives | NQO2, MCL1, KRAS | KMT2A 944/4885ALDH1A1 3206/4885MAPT 2491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.